New AI capabilities will help scientists identify, optimize, and validate new molecules. Additional applications include manufacturing, medical imaging, and enterprise AI agents
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
Subscribe To Our Newsletter & Stay Updated
